Skip to content
AnalystLens

DuPont de Nemours 8-K Report, Financial Results (Nov 3, 2026)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed November 3, 2026
Period End
November 3, 2026
Security
DD
In the record · 2017–202610-K910-Q288-K127

DD filed 9 annual reports (10-K), 28 quarterly reports (10-Q) and 127 current reports (8-K) between 2017 and 2026.

  1. Impairment8-K · May ’19May ’19
  2. Deal closed8-K · Feb ’21Feb ’21
  3. Deal closed8-K · Nov ’22Nov ’22
  4. Leadership change8-K · Jan ’26Jan ’26

01—Abstract

Summary

Summary of the 8-K filed November 3, 2026. Cited figures are marked; the original filing is the authoritative source.

DuPont de Nemours, Inc. filed this Form 8-K on November 3, 2026 to furnish a press release (Exhibit 99.1) announcing third quarter 2026 results, which are presented on a continuing operations basis.

Net sales were $1,868 milliona, up 4% from $1,795 million a year earlier, with organic sales up 5% and a 1% currency headwind. GAAP income from continuing operations rose to $171 million from $102 million, and GAAP EPS from continuing operations was $1.24 versus $0.70. Operating EBITDA was $469 million, up 8%, with the margin at 25.1% versus 24.3%.

Adjusted EPS was $2.09b compared with $1.29, a 62% increase. Cash provided by operating activities from continuing operations was $410 million, and transaction-adjusted free cash flow was $341 million, representing 121% conversion. During the quarter the company completed a $250 million accelerated share purchase and substantially completed $100 million of open market repurchases, and it announced an intent to repurchase $250 million of shares in the fourth quarter.

Management raised full-year 2026 guidance, now expecting net sales of about $7,190 millionc, operating EBITDA of about $1,785 million, organic growth of about 4.5%, and adjusted EPS of $7.47 to $7.52. The fourth-quarter outlook calls for net sales of about $1,825 million and adjusted EPS of $1.90 to $1.95. Healthcare & Water Technologies and Diversified Industrials each reported 4% organic sales growth in the quarter, although Water Technologies cited continued disruptions in the Middle East.

02—Key points

Key Highlights

  1. Third quarter net sales of $1,868 million rose 4%, with organic sales up 5% and a 1% currency headwind.
  2. GAAP EPS from continuing operations was $1.24, up from $0.70; adjusted EPS was $2.09, up from $1.29.
  3. Operating EBITDA of $469 million rose 8%, with margin expanding to 25.1% from 24.3%.
  4. Transaction-adjusted free cash flow was $341 million, representing 121% conversion, with operating cash flow from continuing operations of $410 million.
  5. Full-year 2026 guidance was raised: net sales of about $7,190 million, operating EBITDA of about $1,785 million, and adjusted EPS of $7.47 to $7.52.
  6. The company completed a $250 million accelerated share purchase and substantially completed $100 million of open market repurchases in the quarter, and intends to repurchase $250 million of shares in the fourth quarter.
  7. Results reflect the Aramids divestiture completed April 1, 2026 and the November 1, 2025 Electronics separation, both presented as discontinued operations.

03—Questions

Frequently Asked Questions

  1. How did DuPont perform in the third quarter of 2026?

    Net sales rose 4% to $1,868 million on 5% organic growth, partly offset by a 1% currency headwind. Operating EBITDA increased 8% to $469 million, and adjusted EPS rose to $2.09 from $1.29.

  2. What changed in the company's full-year 2026 outlook?

    DuPont raised its full-year 2026 guidance. It now expects net sales of about $7,190 million, operating EBITDA of about $1,785 million, organic growth of about 4.5%, and adjusted EPS of $7.47 to $7.52. Management said these are at or above the high end of previously communicated guidance.

  3. How strong was the company's cash generation?

    Cash provided by operating activities from continuing operations was $410 million in the quarter. After $71 million of capital expenditures and $2 million of separation-related costs, transaction-adjusted free cash flow was $341 million, a 121% conversion rate.

  4. What capital return actions did DuPont take or plan?

    The company completed a $250 million accelerated share purchase and substantially completed $100 million of open market repurchases in the third quarter. It announced an intent to repurchase another $250 million of shares in the fourth quarter.

  5. What factors affected the segments?

    Healthcare & Water Technologies grew 4% organically, led by personal protection and medical packaging, with Water Technologies affected by continued Middle East disruptions. Diversified Industrials grew 5% organically, with building technologies and industrial technologies both up mid-single digits.

04—Continue

← View all 8-K filings